Scpharmaceuticals Inc (SCPH) — Financial Flexibility Index
Scpharmaceuticals Inc (SCPH) has a Financial Flexibility Index of -0.16x as of June 2025. Free cash flow of $-16.11 Million (operating CF $-16.11 Million minus capex $0.00) represents 0% of total liabilities ($101.57 Million). Check tangible equity quality of Scpharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Scpharmaceuticals Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Scpharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see SCPH cash generation efficiency.
Annual Financial Flexibility Index for Scpharmaceuticals Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Scpharmaceuticals Inc. Explore Scpharmaceuticals Inc (SCPH) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.75x | $-70.52 Million | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.20 Million | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.56 Million | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.14 Million | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.68 Million | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.43 Million | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.80 Million | $-28.81 Million | $15.01 Million | ▼ -37.0% |
| 2017 | -1.40x | $-22.49 Million | $-22.68 Million | $16.05 Million | ▼ -597.0% |
| 2016 | -0.20x | $-15.45 Million | $-15.46 Million | $76.85 Million | ▲ +58.0% |
| 2015 | -0.48x | $-9.62 Million | $-9.64 Million | $20.09 Million | — |